Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RAS-targeted therapies: is the undruggable drugged?
Amanda R. Moore, Scott Rosenberg, Frank McCormick, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 533-552
Open Access | Times Cited: 810

Showing 1-25 of 810 citing articles:

PROTAC targeted protein degraders: the past is prologue
Miklós Békés, David R. Langley, Craig M. Crews
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 181-200
Open Access | Times Cited: 1807
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 828
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 519
Advances in covalent drug discovery
Lydia Boike, Nathaniel J. Henning, Daniel K. Nomura
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 881-898
Open Access | Times Cited: 469
Acquired Resistance to KRASG12C Inhibition in Cancer
Mark M. Awad, Shengwu Liu, Igor I. Rybkin, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 25, pp. 2382-2393
Open Access | Times Cited: 438
Signaling pathways and defense mechanisms of ferroptosis
Jiao Liu, Rui Kang, Daolin Tang
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 7038-7050
Open Access | Times Cited: 396
Immune modulatory effects of oncogenic KRAS in cancer
Shaima’a Hamarsheh, Olaf Groß, Tilman Brummer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 272
Molecular targeted therapy for anticancer treatment
Hye‐Young Min, Ho‐Young Lee
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 10, pp. 1670-1694
Open Access | Times Cited: 240
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
Samantha B. Kemp, Noah Cheng, Nune Markosyan, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 298-311
Open Access | Times Cited: 220
FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC
Erica C. Nakajima, Nicole Drezner, Xiaoxue Li, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 8, pp. 1482-1486
Open Access | Times Cited: 216
Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments
Hon Yan Kelvin Yip, Antonella Papa
Cells (2021) Vol. 10, Iss. 3, pp. 659-659
Open Access | Times Cited: 201
The metabolic landscape of RAS-driven cancers from biology to therapy
Suman Mukhopadhyay, Matthew G. Vander Heiden, Frank McCormick
Nature Cancer (2021) Vol. 2, Iss. 3, pp. 271-283
Open Access | Times Cited: 197
Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants
Marco H. Hofmann, Daniel Gerlach, Sandra Misale, et al.
Cancer Discovery (2022) Vol. 12, Iss. 4, pp. 924-937
Open Access | Times Cited: 195
Immunomodulation by targeted anticancer agents
Giulia Petroni, Aitziber Buqué, Laurence Zitvogel, et al.
Cancer Cell (2020) Vol. 39, Iss. 3, pp. 310-345
Open Access | Times Cited: 179
An expanded universe of cancer targets
William C. Hahn, Joel S. Bader, Theodore P. Braun, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1142-1155
Open Access | Times Cited: 179
Cancer nanotechnology: current status and perspectives
Jessica A. Kemp, Young Jik Kwon
Nano Convergence (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 175
KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments
T. Koga, Kenichi Suda, Toshio Fujino, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 8, pp. 1321-1332
Open Access | Times Cited: 171
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Samuel A. Kerk, Thales Papagiannakopoulos, Yatrik M. Shah, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 510-525
Open Access | Times Cited: 153
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation
Adrian G. Sacher, Patricia LoRusso, Manish R. Patel, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 8, pp. 710-721
Open Access | Times Cited: 151
An overview of PROTACs: a promising drug discovery paradigm
Liu Zi, Mingxing Hu, Yang Yu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 147
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies
Jing Zhou, Qing Ji, Qi Li
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 145
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 144
Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression
Fabiola Lilí Sarmiento-Salinas, Andrea Perez-Gonzalez, Adilene Acosta-Casique, et al.
Life Sciences (2021) Vol. 284, pp. 119942-119942
Closed Access | Times Cited: 141
Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation
Tanios Bekaii‐Saab, Rona Yaeger, Alexander I. Spira, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 25, pp. 4097-4106
Open Access | Times Cited: 140
Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications
Shanliang Zheng, Xingwen Wang, Dong Zhao, et al.
Trends in Cell Biology (2022) Vol. 33, Iss. 4, pp. 312-323
Open Access | Times Cited: 137
Page 1 - Next Page

Scroll to top